Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia;Fatores de risco para multirresistência bacteriana em pneumonias adquiridas no hospital não associadas à ventilação mecânica

Jornal Brasileiro de Pneumologia

Volumn 39, Issue 3, 2013, Pages 339-348

  Seligman, Renato ^a   Ramos Lima, Luis Francisco ^a   Oliveira, Vivian do Amaral ^a   Sanvicente, Carina ^a   Sartori, Juliana ^a   Pacheco, Elyara Fiorin ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Bacterial; Cross infection; Drug resistance; Pneumonia

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; BRAZIL; CHILD; CROSS INFECTION; DRUG EFFECT; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; MULTIDRUG RESISTANCE; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TEACHING HOSPITAL; TERTIARY CARE CENTER; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BRAZIL; CARBAPENEMS; CEPHALOSPORINS; CHILD; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, TEACHING; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PENICILLINS; PNEUMONIA, BACTERIAL; PREDICTIVE VALUE OF TESTS; QUINOLONES; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84879996930     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132013000300011     Document Type: Article

References (30)

1. Guidelines for prevention of nosocomial pneumonia. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1997;46(RR-1):1-79.
2. Flanders SA, Collard HR, Saint S. Nosocomial pneumonia: state of the science. Am J Infect Control. 2006;34(2):84-93. http://dx.doi.org/10.1016/j.ajic.2005.07.003 PMid:16490612
3. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416. http://dx.doi.org/10.1164/rccm.200405-644ST PMid:15699079
4. Rotstein C, Evans G, Born A, Grossman R, Light RB, Magder S, et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol. 2008;19(1):19-53. PMid:19145262 PMCid:2610276
5. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 1999;27(5):887-92. http://dx.doi.org/10.1097/00003246-199905000-00020 PMid:10362409
6. Celis R, Torres A, Gatell JM, Almela M, Rodríguez-Roisin R, Agustí-Vidal A. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest. 1988;93(2):318-24. http://dx.doi.org/10.1378/chest.93.2.318 PMid:3338299
7. Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1165-72. http://dx.doi.org/10.1164/ajrccm.157.4.9708057 PMid:9563735
8. Sociedade Brasileira de Pneumologia e Tisiologia. Brazilian guidelines for treatment of hospital acquired pneumonia and ventilator associated pneumonia-2007 [Article in Portuguese]. J Bras Pneumol. 2007;33(Suppl 1):S1-30. PMid:18833653
9. Depuydt PO, Vandijck DM, Bekaert MA, Decruyenaere JM, Blot SI, Vogelaers DP, et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care. 2008;12(6):R142. http://dx.doi.org/10.1186/cc7119 PMid:19014695 PMCid:2646301
10. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157(2):531-9. http://dx.doi.org/10.1164/ajrccm.157.2.9705064 PMid:9476869
11. Zahar JR, Clec'h C, Tafflet M, Garrouste-Orgeas M, Jamali S, Mourvillier B, et al. Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia? Clin Infect Dis. 2005;41(9):1224-31. http://dx.doi.org/10.1086/496923 PMid:16206094
12. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1545-9. http://dx.doi.org/10.1164/ajrccm.150.6.7952612 PMid:7952612
13. Sociedade Brasileira de Pneumologia e Tisiologia. Consenso Brasileiro de Pneumonias em Indivíduos Adultos Imunocompetentes. J Pneumol. 2001;27(Suppl 1):1-40.
14. Balthazar AB, Von Nowakonski A, De Capitani EM, Bottini PV, Terzi RG, Araújo S. Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Braz J Med Biol Res. 2001;34(8):993-1001. http://dx.doi.org/10.1590/S0100-879X2001000800004 PMid:11471037
15. Sader HS, Mendes RE, Gales AC, Jones RN, Pfaller MA, Zoccoli C, et al. Perfil de sensibilidade a antimicrobianos de bactérias isoladas do trato respiratório baixo de pacientes com pneumonia internados em hospitais brasileiros: resultados do Programa SENTRY, 1997 e 1998. J Pneumol. 2001;27(2):59-67. http://dx.doi.org/10.1590/S0102-35862001000200002
16. Carrilho CM. Fatores associados ao risco de desenvolvimento de pneumonia hospitalar na Unidade de Terapia Intensiva do Hospital Universitário Regional do Norte do Paraná, Londrina, PR. Rev Soc Bras Med Trop. 1999;32(4):455-6. http://dx.doi.org/10.1590/S0037-86821999000400021
17. Korn GP, Martino MD, Mimica IM, Mimica LJ, Chiavone PA, Musolino LR. High frequency of colonization and absence of identifiable risk factors for methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units in Brazil. Braz J Infect Dis. 2001;5(1):1-7. http://dx.doi.org/10.1590/S1413-86702001000100001 PMid:11290308
18. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis. 2002;34(8):1047-54. http://dx.doi.org/10.1086/339488 PMid:11914992
19. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother. 1999;43(6):1379-82. PMid:10348756 PMCid:89282
20. Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother. 2002;46(3):854-8. http://dx.doi.org/10.1128/AAC.46.3.854-858.2002 PMid:11850272 PMCid:127481
21. Kaminski C, Timsit JF, Dubois Y, Zahar JR, Garrouste-Orgeas M, Vesin A, et al. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care. 2011;15(2):R112. http://dx.doi.org/10.1186/cc10136 PMid:21481266 PMCid:3219393
22. Zavascki AP, Barth AL, Fernandes JF, Moro AL, Gonçalves AL, Goldani LZ. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study. Crit Care. 2006;10(4):R114. http://dx.doi.org/10.1186/cc5006 PMid:16882337 PMCid:1751023
23. Furtado GH, Martins ST, Coutinho AP, Soares GM, Wey SB, Medeiros EA. Incidence of vancomycin-resistant Enterococcus at a university hospital in Brazil [Article in Portuguese]. Rev Saude Publica. 2005;39(1):41-6. http://dx.doi.org/10.1590/S0034-89102005000100006 PMid:15654459
24. Paramythiotou E, Lucet JC, Timsit JF, Vanjak D, Paugam-Burtz C, Trouillet JL, et al. Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis. 2004;38(5):670-7. http://dx.doi.org/10.1086/381550 PMid:14986251
25. Yu VL. Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia: a vulnerability, a pitfall, and a fatal flaw. Lancet Infect Dis. 2011;11(3):248-52. http://dx.doi.org/10.1016/S1473-3099(11)70005-6
26. Rodrigues PM, Carmo Neto Ed, Santos LR, Knibel MF. Ventilator-associated pneumonia: epidemiology and impact on the clinical evolution of ICU patients. J Bras Pneumol. 2009;35(11):1084-91. http://dx.doi.org/10.1590/S1806-37132009001100005 PMid:20011843
27. Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Curr Opin Crit Care. 2006;12(5):452-7. http://dx.doi.org/10.1097/01.ccx.0000244126.84989.a2 PMid:16943725
28. Clec'h C, Timsit JF, De Lassence A, Azoulay E, Alberti C, Garrouste-Orgeas M, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity. Intensive Care Med. 2004;30(7):1327-33. http://dx.doi.org/10.1007/s00134-004-2292-7 PMid:15197443
29. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125(5):1791-9. http://dx.doi.org/10.1378/chest.125.5.1791 PMid:15136392
30. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest. 2006;129(5):1210-8. Erratum in: Chest. 2006;130(1):308. http://dx.doi.org/10.1378/chest.129.5.1210 PMid:16685011